Explore - Secure - Protect RNA Innovations

CAS Can Help You Accelerate R&D and Protect Your Investments

CAS works daily with companies pioneering new RNA therapies. Learn how our expertise in this growing area can help you explore, secure and protect RNA innovations.

 

 

The enormous growth in RNA-based drug development adds complexities to IP management that can put your substantial investments in new products at risk and lead to future legal conflicts. 

In this CAS presentation from the 2021 RNA Therapeutics Conference, we share insights that can improve how you:

  • Manage patents to enrich and protect your inventions
  • Minimize risks to IP value in the increasingly crowded RNA space
  • Navigate complex RNA patent information for quality business insights

The RNA patent landscape is growing and highly complex. Missed IP and scientific information can put investments at risk! Contact Us and let us know how we can help you.

Avoid Pitfalls in RNA Drug Development brochure cover

Download the brochure: Avoid Patent Pitfalls in RNA Drug Development 
 

Challenges Solved

Meet the mRNA vaccine rookies aiming to take down COVID-19

mRNA vaccines have many potential advantages over conventional vaccines in mitigating the spread and eventually ending the COVID-19 pandemic. Learn …

Read more
RNAi patenting trend
Articles

Protecting and Commercializing the Promise of RNAi

In this article from The Patent Lawyer Magazine, Anne Marie Clark, Senior Search Analyst for CAS, discusses how to avoid patent pitfalls as the market …

Read more

Protect the Promise of Your RNAi Innovations

The value and complexity of the patent landscape around RNA interference (RNAi) is increasing, creating special challenges for patent searches to …

Read more

Contact Us to Learn More

Your privacy is important to CAS. More detail about how we use your information is in our privacy policy.